When in pathological status of adult-onset Still's disease, the production of CXCL13 was up-regulated, and it was regarded as a crucial chemokine in the establishment of the adaptive immune response in the pathogenesis (Han et al., 2015). This evidence concerns the gene CXCL13 and adult-onset Still disease.